Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
New Treatments (Msc) in Immune Disorders Like Cancers and Covid Infection: Cancer and Virus New Treatment (Msc) Publisher



Darestani NG1 ; Hashemi S2 ; Rahimi Z3 ; Poodeh RJ4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Fellowship of Stem Cell and Regenerative Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Experimental Sciences of Farhangian Isfahan University, Isfahan, Iran
  4. 4. Chamran Subspecialty Hospital and Research Center of Heart, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Asia Pacific Journal of Cancer Biology Published:2024


Abstract

The recent coronavirus disease 2019 outbreak and viral infections around the world has had an enormous impact on the global health burden, threatening the lives of many individuals, spatially with underlying disease like cancerous patients and has had severe socio-economic consequences. Many pharmaceutical and biotechnology companies have commenced intensive research on different therapeutic strategies, from repurposed antiviral drugs to vaccines and monoclonal antibodies to prevent the spread of the disease and treat infected patients. Among the various strategies, advanced therapeutic approaches including cell- and gene-editing-based therapeutics are also being investigated, and initial results in in-vitro and early phase I studies have been promising. However, further assessments are required. This article reviews the underlying mechanisms for the pathogenesis of, and discusses available therapeutic candidates and advanced modalities that are being evaluated and used for treatment for immune deficient patients in cancers and viruses infected. © (2024), (West Asia Organization for Cancer Prevention). All rights reserved.
Related Docs
View other Related Docs
1. Pi3k/Akt/Mtor Pathway: A Potential Target for Anti-Sars-Cov-2 Therapy, Immunologic Research (2022)
2. Mesenchymal Stem Cells: A Potent Cell Source for Covid-19, Coronaviruses (2021)
3. Medicinal Chemistry of Antisense Oligonucleotides for Therapeutic Use in Sars-Cov-2: Design Strategies and Challenges for Targeted Delivery, Current medicinal chemistry (2025)
4. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
5. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
6. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
7. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
8. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
Experts (# of related papers)
View all Related Experts
Hossein Khanahmad (5)
Hamid Bakherad (4)
Other Related Docs
9. Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection, Acta Medica Indonesiana (2021)
10. Sars-Cov-2 Variant-Specific Mrna Vaccine: Pros and Cons, Viral Immunology (2023)
11. Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?, Dermatologic Therapy (2020)
12. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
13. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
14. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
15. Coenzyme Q10 and Its Therapeutic Potencies Against Covid-19 and Other Similar Infections: A Molecular Review, Advanced Pharmaceutical Bulletin (2023)
16. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
17. Hypotheses for Reactivation Recurrence and Reinfection Recurrence of Covid-19, Applied Biological Research (2021)
18. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe Covid-19 Patients in Intensive Care Unit, Archives of Iranian Medicine (2021)
19. Important Roles of Oligo-And Polysaccharides Against Sars-Cov-2: Recent Advances, Applied Sciences (Switzerland) (2021)
20. Comprehensive Overview of Covid-19-Related Respiratory Failure: Focus on Cellular Interactions, Cellular and Molecular Biology Letters (2022)
21. Screening of Potential Inhibitors of Covid-19 With Repurposing Approach Via Molecular Docking, Network Modeling Analysis in Health Informatics and Bioinformatics (2022)
22. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
23. Controlling and Prevention of Novel Coronavirus Through Health and Safety Protocols in Food: Review Article, Tehran University Medical Journal (2021)
24. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
25. Mechanisms of Covid-19 Entry Into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in Covid-19 Patients With Underlying Diseases, Iranian journal of allergy, asthma, and immunology (2021)
26. Nanosponges: An Overlooked Promising Strategy to Combat Sars-Cov-2, Drug Discovery Today (2022)
27. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
28. Covid19 Prevention & Care; a Cancer Specific Guideline, Archives of Iranian Medicine (2020)
29. Aptamers, the Bivalent Agents As Probes and Therapies for Coronavirus Infections: A Systematic Review, Molecular and Cellular Probes (2020)
30. Covid-19 Vaccines: Current and Future Challenges, Frontiers in Pharmacology (2024)
31. Genetic Advancements in Breast Cancer Treatment: A Review, Discover Oncology (2025)
32. A Mini-Review on Sofosbuvir and Daclatasvir Treatment in Coronavirus Disease 2019, New Microbes and New Infections (2021)
33. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
34. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
35. Using in Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the Sars-Cov-2 Virus and Analysis of Potential Therapeutic Targets, Biochemical Genetics (2023)
36. Conceptual Framework for Sars-Cov-2-Related Lymphopenia, Advanced Biomedical Research (2022)
37. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
38. Improvement of K562 Cell Line Transduction by Fbs Mediated Attachment to the Cell Culture Plate, BioMed Research International (2019)
39. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)
40. Genetics and Genomics of Sars-Cov-2: A Review of the Literature With the Special Focus on Genetic Diversity and Sars-Cov-2 Genome Detection, Genomics (2021)
41. Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions, Probiotics and Antimicrobial Proteins (2025)
42. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
43. Chitin and Chitosan As Tools to Combat Covid-19: A Triple Approach, International Journal of Biological Macromolecules (2021)
44. Outlook of Therapeutic and Diagnostic Competency of Nanobodies Against Sars-Cov-2: A Systematic Review, Analytical Biochemistry (2022)
45. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
46. The Mrna Vaccines and Their Application to Combat Infectious Diseases and Cancers: A Review Article, Journal of Isfahan Medical School (2023)
47. Selective Serotonin Reuptake Inhibitors: New Hope in the Fight Against Covid-19, Frontiers in Pharmacology (2022)
48. The Kinetics of Inhibitory Immune Checkpoints During and Post-Covid-19: The Knowns and Unknowns, Clinical and Experimental Medicine (2023)
49. Exploring Advanced Crispr Delivery Technologies for Therapeutic Genome Editing, Small Science (2024)
50. Nanomaterials and Nanotechnology-Associated Innovations Against Viral Infections With a Focus on Coronaviruses, Nanomaterials (2020)